George Hofmeyr to Contraceptive Agents, Female
This is a "connection" page, showing publications George Hofmeyr has written about Contraceptive Agents, Female.
Connection Strength
4,988
-
Effects of injectable contraception with depot medroxyprogesterone acetate or norethisterone enanthate on estradiol levels and menstrual, psychological and behavioral measures relevant to HIV risk: The WHICH randomized trial. PLoS One. 2024; 19(3):e0295764.
Score: 0,868
-
Effects of depot medroxyprogesterone acetate, the copper IUD and the levonorgestrel implant on testosterone, sex hormone binding globulin and free testosterone levels: ancillary study of the ECHO randomized clinical trial. BMC Womens Health. 2024 Mar 08; 24(1):167.
Score: 0,865
-
Behavioral effects of different contraceptive methods and HIV acquisition: an ancillary study of the ECHO randomized trial. Reprod Health. 2021 Sep 29; 18(1):192.
Score: 0,730
-
Effects of the copper intrauterine device versus injectable progestin contraception on pregnancy rates and method discontinuation among women attending termination of pregnancy services in South Africa: a pragmatic randomized controlled trial. Reprod Health. 2016 Apr 18; 13:42.
Score: 0,501
-
Interpretation, communication, and mechanisms of associations between injectable contraception and HIV risk. Lancet HIV. 2015 Sep; 2(9):e365.
Score: 0,479
-
Hypothesis: amenorrhea-inducing contraception may reduce HIV acquisition risk. Contraception. 2014 Dec; 90(6):615-6.
Score: 0,448
-
Copper containing intra-uterine devices versus depot progestogens for contraception. Cochrane Database Syst Rev. 2010 Jun 16; (6):CD007043.
Score: 0,334
-
The injectable contraceptives depot medroxyprogesterone acetate and norethisterone enanthate substantially and differentially decrease testosterone and sex hormone binding globulin levels: A secondary study from the WHICH randomized clinical trial. PLoS One. 2024; 19(8):e0307736.
Score: 0,223
-
Sexual behaviour among women using intramuscular depot medroxyprogesterone acetate, a copper intrauterine device, or a levonorgestrel implant for contraception: Data from the ECHO randomized trial. PLoS One. 2024; 19(5):e0299802.
Score: 0,219
-
Effects of three contraceptive methods on depression and sexual function: An ancillary study of the ECHO randomized trial. Int J Gynaecol Obstet. 2021 Aug; 154(2):256-262.
Score: 0,175
-
Changes to the World Health Organization guideline on hormonal contraceptive eligibility for women at high risk of HIV: South African perspective and response. S Afr Med J. 2018 Jul 25; 108(8):629-631.
Score: 0,146